Join Growin Stock Community!

普瑞博6847.TW Overview

TW StockBiotech. & Medical
(No presentation for 6847)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

普瑞博（6847）Overall Performance

普瑞博（6847）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

普瑞博（6847） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

普瑞博（6847）Key Information

普瑞博（6847）Profile

Puriblood Medical Co., Ltd. develops and sells blood cell separation products in Taiwan. The company offers leukocyte reduction filters for red blood cells, platelets, and whole blood, as well as real-time filtration sets for whole blood. It also offers Devin blood fractionation membrane filters and Minipuri cell screening syringe filters. In addition, the company develops P-Tex Technology, which is composed by bio-inspired molecular formula – zwitterionic copolymer structure. Puriblood Medical Co., Ltd. was founded in 2016 and is based in Hsinchu City, Taiwan.

普瑞博（6847）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-4.15
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
4.36
PB Ratio
6.47
Price-to-FCF
26.12
METRIC
VALUE
vs. INDUSTRY
Gross Margin
29.27%
Net Margin
-24.34%
Revenue Growth (YoY)
26.34%
Profit Growth (YoY)
10.52%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-4.15
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
4.36
PB Ratio
6.47
Price-to-FCF
26.12
Gross Margin
29.27%
Net Margin
-24.34%
Revenue Growth (YoY)
26.34%
Profit Growth (YoY)
10.52%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
default symbol

6847

普瑞博

74.30D

0.00%

(0.00)

  • When is 6847's latest earnings report released?

    The most recent financial report for 普瑞博 (6847) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 6847's short-term business performance and financial health. For the latest updates on 6847's earnings releases, visit this page regularly.

  • How much cash does 6847 have?

    At the end of the period, 普瑞博 (6847) held Total Cash and Cash Equivalents of 80.75M, accounting for 0.32 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 6847 go with three margins increasing?

    In the latest report, 普瑞博 (6847) did not achieve the “three margins increasing” benchmark, with a gross margin of 48.5%%, operating margin of -26.18%%, and net margin of -36.08%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 6847's profit trajectory and future growth potential.